From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves 1st US biosimilar; hold your breath on cost savings

from Forbes

In a much-anticipated decision, the Food and Drug Administration announced this morning the approval of filgrastim-sndz, the first non-brand, complex biopharmaceutical — or biosimilar — in U.S. pharmaceutical history. The drug, made by Sandoz, will be sold in the U.S. under the much simpler brand name, Zarxio. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063